Genetic aspects of pancreatitis

Annual Review of Medicine

Volumn 61, Issue , 2010, Pages 413-424

  Whitcomb, David C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Acute pancreatitis; Chronic pancreatitis; Cystic fibrosis; Hyperlipidemia; Hypertriglyceridemia

Indexed keywords

ALCOHOL; CALCIUM SENSING RECEPTOR; CHYMOTRYPSINOGEN; CHYMOTRYPSINOGEN C; CYTOKINE; ENZYME INHIBITOR; SERINE PROTEASE INHIBITOR KAZAL 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN; UNCLASSIFIED DRUG; TRYPSIN;

ACUTE PANCREATITIS; AUTOMUTILATION; CHRONIC PANCREATITIS; DIGESTIVE SYSTEM INFLAMMATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HYPERCALCEMIA; HYPERLIPIDEMIA; PANCREAS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THINKING; HUMAN; HYPERTRIGLYCERIDEMIA; METABOLISM; PANCREATITIS; PATHOLOGY; PHYSIOLOGY;

HUMANS; HYPERTRIGLYCERIDEMIA; PANCREATITIS; RISK FACTORS; TRYPSIN;

EID: 77951920963     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.041608.121416     Document Type: Review

References (59)

1. Whitcomb DC. 2004. Mechanisms of disease: advances in understanding the mechanisms leading to chronic pancreatitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 1(1):46-52
2. Simon P, Weiss FU, Zimmer KP, et al. 2001. Acute and chronic pancreatitis in patients with inborn errors of metabolism. Pancreatology 1(5):448-456
3. Wilson DE, Hata A, Kwong LK, et al. 1993. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes. J. Clin. Invest. 92(1):203-211
4. Tsuang W, Navaneethan U, Ruiz L, et al. 2009. Hypertriglyceridemic pancreatitis: presentation and management. Am. J. Gastroenterol. 104(4):984-991
5. Wang Y, Sternfeld L, Yang F, et al. 2009. Enhanced susceptibility to pancreatitis in severe hypertriglyceri-daemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut 58(3):422-430
6. Saharia P, Margolis S, Zuidema GD, et al. 1977. Acute pancreatitis with hyperlipemia: studies with an isolated perfused canine pancreas. Surgery 82(1):60-67
7. Chang YT, Chang MC, Su TC, et al. 2008. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin. Chem. 54(1):131-138
8. Lee JH, Choi JH, Namkung W, et al. 2003. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum. Mol. Genet. 12(18):2321-2332
9. Steiner B, Truninger K, Sanz J, et al. 2004. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles. Hum. Mutat. 24(2):120-129
10. de-Madaria E, Martinez J, Sempere L, et al. 2008. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood. Pancreas 37(3):295-301
11. Dinarello CA, Gelfand JA, Wolff SM. 1993. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269(14):1829-1835
12. Cavaillon JM, Adrie C, Fitting C, et al. 2005. Reprogramming of circulatory cells in sepsis and SIRS. J. Endotoxin Res. 11(5):311-320
13. Matsuda N, Hattori Y. 2006. Systemic inflammatory response syndrome (SIRS): molecular pathophysi-ology and gene therapy. J. Pharmacol. Sci. 101(3):189-198
14. Tukiainen E, Kylanpaa ML, PuolakkainenP, et al. 2008. Polymorphismsofthe TNF, CD14, and HSPA1B genes in patients with acute alcohol-induced pancreatitis. Pancreas 37(1):56-61
15. Powell JJ, Fearon KC, Siriwardena AK, et al. 2001. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 129(5):633-640
16. Sargen K, Demaine AG, Kingsnorth AN. 2000. Cytokine gene polymorphisms in acute pancreatitis. J. Pancreas 1(2):24-35
17. Balog A, Gyulai Z, Boros LG, et al. 2005. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 30(2):e46-50
18. Zhang D, Li J, Jiang ZW, et al. 2003. Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. J. Surg. Res. 112(2):138-143 (Pubitemid 36904038)
19. Holmes CL, Russell JA, Walley KR. 2003. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124(3):1103-1115
20. Mira JP, Cariou A, Grall F, et al. 1999. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282(6):561-568
21. Szmola R, Sahin-Toth M. 2007. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc. Natl. Acad. Sci. USA 104(27):11227-11232
22. Rinderknecht H, Adham NF, Renner IG, et al. 1988. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion. Int. J. Pancreatol. 3:33-44
23. Rosendahl J, Witt H, Szmola R, et al. 2008. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat. Genet. 40(1):78-82
24. Masson E, Chen JM, Scotet V, et al. 2008. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum. Genet. 123(1):83-91
25. Whitcomb DC, Lowe ME. 2007. Human pancreatic digestive enzymes. Dig. Dis. Sci. 52(1):1-17
26. 2+-sensing receptor from bovine parathyroid. Nature 366(6455):575-580
27. Pidasheva S, D'Souza-Li L, Canaff L, et al. 2004. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyper-parathyroidism, and autosomal dominant hypocalcemia. Hum. Mutat. 24(2):107-111
28. 2+(polyvalent cation)-sensing receptor in rat pancreas. J. Biol. Chem. 274(29):20561-20568
29. Felderbauer P, Hoffmann P, Einwachter H, et al. 2003. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol. 3(1):34
30. Felderbauer P, Karakas E, Fendrich V, et al. 2008. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am. J. Gastroenterol. 103(2):368-374
31. Murugaian EE, Premkumar RM, Radhakrishnan L, et al. 2008. Novel mutations in the calcium sensing receptor gene in tropical chronic pancreatitis in India. Scand. J. Gastroenterol. 43(1):117-121
32. Muddana V, Lamb J, Greer JB, et al. 2008. Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1 type and alcohol. World J. Gastroenterol. 14(28):4486-4491
33. 2+ signalling and pancreatitis: effects of alcohol, bile and coffee. Trends Pharmacol. Sci. 27(2):113-120
34. Whitcomb DC, Gorry MC, Preston RA, et al. 1996. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 14(2):141-145
35. Gorry MC, GabbaizedehD,FureyW,etal. 1997. Mutationsinthe cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 113(4):1063-1068
36. Witt H, Luck W, Becker M. 1999. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 117:7-10
37. Rebours V, Boutron-Ruault MC, Schnee M, et al. 2009. The natural history of hereditary pancreatitis: a national series. Gut 58(1):97-103
38. Liu QC, Gao F, Ou QS, et al. 2008. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis. Chin. Med. J. 121(2):108-111
39. Teich N, Mossner J, Keim V. 1998. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum. Mut. 12(1):39-43
40. Felderbauer P, Schnekenburger J, Lebert R, et al. 2008. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site. J. Med. Genet. 45(8):507-512
41. Oh HC, Kim MH, Choi KS, et al. 2009. Analysis of PRSS1 and SPINK1 mutations in Korean patients with idiopathic and familial pancreatitis. Pancreas 38(2):180-183
42. Chen JM, Ferec C. 2000. Gene conversion-like missense mutations in the human cationic trypsinogen gene and insights into the molecular evolution of the human trypsinogen family. Mol. Genet. Metab. 71(3):463-469
43. Teich N, Nemoda Z, Kohler H, et al. 2005. Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl. Hum. Mutat. 25(4):343-347
44. Masson E, Le Marechal C, Chandak GR, et al. 2008. Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. Clin. Gastroenterol. Hepatol. 6(1):82-88
45. Masson E, Le Marechal C, Delcenserie R, et al. 2008. Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum. Genet. 123(5):521-529
46. Masson E, Le Marechal C, Chen JM, et al. 2008. Absence of mesotrypsinogen gene (PRSS3) copy number variations in patients with chronic pancreatitis. Pancreas 37(2):227-228
47. Witt H, Sahin-Toth M, Landt O, et al. 2006. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat. Genet. 38(6):668-673
48. Santhosh S, Witt H, te Morsche RH, et al. 2008. A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis. Pancreas. 36(3):317-320
49. Khalid A, Finkelstein S, Thompson B, et al. 2006. A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance. Gut 55(5):728-731
50. Aoun E, Chang CC, Greer JB, et al. 2008. Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS ONE 3(4):e2003
51. Kereszturi E, Kiraly O, Sahin-Toth M. 2009. Minigene analysis of intronic variants in common SPINK1 haplotypes associated with chronic pancreatitis. Gut 58(4):545-549
52. Whitcomb DC, Ermentrout GB. 2004. A mathematical model of the pancreatic duct cell generating high bicarbonate concentrations in pancreatic juice. Pancreas 29(2):E30-E40
53. Audrezet MP, Dabricot A, Le Marechal C, et al. 2008. Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. J. Mol. Diagn. 10(5):424-434
54. AlghisiF,BellaS,LucidiV,etal. 2009. Phenotypic variability inafamily with pancreatitis and cysticfibrosis sharing common mild CFTR mutation: report on CFTR mutations and their phenotypic variability. Pancreas 38(1):109-110
55. Segal I, Yaakov Y, Adler SN, et al. 2008. Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis. J. Clin. Gastroenterol. 42(7):810-814
56. Laguna TA, Sagel SD, Sontag MK, et al. 2008. The clinical course of a Mexican female with cystic fibrosis and the novel genotype S531P/S531P. J. Cystic Fibrosis 7(5):454-456
57. Whitcomb DC. 2010. Acute and chronic pancreatitis. In Conn's Current Therapy 2010, ed. RE Rakel, ET Bope, R Kellerman. Philadelphia: Saunders. In press
58. Etemad B, Whitcomb DC. 2001. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120:682-707
59. Whitcomb DC, Yadav D, Slivka A, et al. 2008. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology 8:520-531